State Street’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

State Street’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-239,831	Closed	-$71.5K	–	4707
2023 Q2	$71.5K	Sell	239,831 -764,148	-76%	-$230K	﹤0.01%	4312
2023 Q1	$434K	Sell	1,003,979 -196,239	-16%	-$151K	﹤0.01%	3788
2022 Q4	$1.42M	Buy	1,200,218 +388,497	+48%	+$633K	﹤0.01%	3473
2022 Q3	$1.88M	Buy	811,721 +421,797	+108%	+$1.1M	﹤0.01%	3434
2022 Q2	$862K	Buy	389,924 +191,893	+97%	+$1.33M	﹤0.01%	3668
2022 Q1	$1.91M	Buy	+198,031	New	+$1.77M	﹤0.01%	3583

State Street's GRNA Position: Q3 2023 in Review

State Street sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 239,831 shares — an estimated $71.5K sold.

State Street first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $1.91M in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

State Street reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
State Street sold 239,831 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $71.5K.
State Street first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
State Street's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.91M in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.